Seqirus’ Received Health Canada approval of first cell-based seasonal influenza vaccine
On Dec. 11, 2019, Seqirus announced that its cell-based quadrivalent influenza vaccine (QIVc) had received approval from Health…
On Dec. 11, 2019, Seqirus announced that its cell-based quadrivalent influenza vaccine (QIVc) had received approval from Health…
On Dec. 4, 2019, PATH announced that its Board of Directors had unanimously chosen global development leader Nikolaj…
On Dec. 3, 2019, the Cold Spring Harbor Laboratory researchers with colleagues at UConn Health and Jackson Laboratory…
On Dec. 2, 2019, the University of Tennessee Institute of Agriculture announced it had received a grant by…
On Nov. 24, 2019, Abu Dhabi Health Services Company, the largest healthcare network in the United Arab Emirates…
On Nov. 22, 2019, the Centers for Disease Control and Prevention”s (CDC) Advisory Committee on Immunization Practices (ACIP)…
On Nov. 20, 2019, University of California San Diego (UCSD) researchers provided new insights into a key pathway…
On Nov. 20, 2019, the Cancer Prevention and Research Institute of Texas (CPRIT) announced the recruitment of its…
On Nov. 20, 2019. Bristol-Myers Squibb announced it had completed its acquisition of Celgene. On Jun. 29, 2015,…
On Nov. 19, 2019, Novo Ventures and the Broad Institute of MIT and Harvard announced the launch of…
On Nov. 13, 2019, researchers at University of California San Diego (UCSD) School of Medicine announced that they…
On Nov. 12, 2019, Calporta Therapeutics, one of eight San Diego biotech companies Avalon Ventures created with GlaxoSmithKline,…
On Nov. 7, 2019, Ceres Nanosciences announced the commercial launch of the Nanotrap Virus Capture Kit. The Nanotrap…
On Nov. 6, 2019, Abbott announced that a team of its scientists identified a new subtype of the…
On Oct. 30, 2019, researchers at the University of Georgia’s Center for the Ecology of Infectious Diseases received…
On Oct. 30, 2019, the Barbara Ann Karmanos Cancer Institute established the McLaren Proton Therapy Center, one of…
On Oct. 27, 2019, the Leona M. and Harry B. Helmsley Charitable Trust announced it had awarded $13…
On Oct. 22, 2019, scientists at Sanford Burnham Prebys announced they had developed a machine-learning algorithm that gleans…
On Oct. 22, 2019, Lundbeck, located in Valby, Denmark, announced it had completed its acquisition of Bothell, Washington-based…
On Oct. 17, 2019, Genentech announced the U.S. Food and Drug Administration (FDA) had approved Xofluza (Baloxavir Marboxil),…
On Oct. 15, 2019, scientists reported that date palms are one of the oldest domesticated perennial crops, with…
On Oct. 7, 2019, Researchers from J. Craig Venter Institute (JCVI), Scripps Institution of Oceanography, and UCSD discovered…
On Oct. 7, 2019, Penn Medicine announced it had developed gene therapy to treat Duchenne muscular dystrophy (DMD)…
On Oct. 3, 2019, the New York State Department of Health announced that more than 42 days –…
On Oct. 2, 2019, the Masonic Cancer Center and the University of Minnesota (UM) opened a new first-in-human…
On Oct 1, 2019, the National Institute on Aging (NIA) announced it had awarded approximately $37 million over…
On Sept. 30, 2019, the University of Georgia (UGA) announced it had signed a contract with the National…
On Sept. 30, 2019, UPenn’s Center for Neurodegenerative Disease Research (CNDR) received an $18.1 million grant from the…
On Sept. 26, 2019, Seattle Children’s announced it was one of three recipients of $30 million in first-year-funding…
On Sept. 25, 2019, UPenn researchers led by Rebecca Wells, MD, announced they had created the first-ever ‘bile…